Antonia Molloy

Dr Antonia Molloy holds a BSc (Hons) in Immunology, a MSc in Precision Medicine, and a PhD Microbiology. She is the entrepreneurial lead in the UKRI ICURe programme, translating a protein nanocage drug delivery platform. Her work focuses on targeted therapeutic delivery to improve formulation, delivery, targeting, and reducing toxicity. Passionate about translational science, she aims to bring innovative treatments from lab to patients.